Precision Wealth Strategies’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
16,303
+6,910
+74% +$587K 0.39% 56
2026
Q1
$809K Buy
9,393
+3,128
+50% +$281K 0.27% 82
2025
Q4
$547K Buy
+6,265
New +$476K 0.18% 115
2025
Q2
Sell
-5,610
Closed -$411K 182
2025
Q1
$411K Sell
5,610
-187
-3% -$15.5K 0.31% 63
2024
Q4
$479K Buy
+5,797
New +$457K 0.37% 53

Other funds holding GMED

Precision Wealth Strategies's GMED Position: Q2 2026 in Review

Precision Wealth Strategies increased its Globus Medical (GMED) stake by 74% in Q2 2026, buying an estimated $587K and bringing the position to 16,303 shares worth $1.29M. The position accounts for 0.39% of the portfolio, ranked #56.

Precision Wealth Strategies first reported a position in GMED in Q4 2024 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Precision Wealth Strategies held 16,303 shares of Globus Medical worth $1.29M as of Q2 2026.
  • Precision Wealth Strategies bought 6,910 Globus Medical shares in Q2 2026, an estimated $587K.
  • Globus Medical made up 0.39% of Precision Wealth Strategies's portfolio in Q2 2026, its #56 holding.
  • Precision Wealth Strategies first reported a position in Globus Medical in Q4 2024 and has held it in 5 quarters since.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Precision Wealth Strategies's 13F filing for Q2 2026, filed 10 Aug 2026.